Paper4158239
Influence of iodine intake after treatment with antithyroid drugs.
Alexander WD and 3 others. Lancet, 1965. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Influence of iodine intake after treatment with antithyroid drugs. Papers, record 4158239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4158239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antithyroid Agents | Major topic |
| Hyperthyroidism | Major topic |
| Potassium Iodide | Major topic |
| Clinical Trials as Topic | |
| Humans | |
| Thyroid Function Tests |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37900151 | Effect of iodine nutritional status on the recurrence of hyperthyroidism and antithyroid drug efficacy in adult patients with Graves' disease: a systemic review. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37900151 | PubMed |
| 28529524 | Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence. | Int J Endocrinol | 2017 | https://conductscience.org/library/papers/28529524 | PubMed |
| 25960960 | Excessive iodine intake does not increase the recurrence rate of graves' disease after withdrawal of the antithyroid drug in an iodine-replete area. | Eur Thyroid J | 2015 | https://conductscience.org/library/papers/25960960 | PubMed |
| 24783027 | Genotype and phenotype predictors of relapse of graves' disease after antithyroid drug withdrawal. | Eur Thyroid J | 2013 | https://conductscience.org/library/papers/24783027 | PubMed |
| 16699308 | Restriction of dietary Iodine does not ameliorate the early effect of anti-thyroid drug therapy for Graves' disease in an area of excessive iodine intake. | J Endocrinol Invest | 2006 | https://conductscience.org/library/papers/16699308 | PubMed |
| 8323210 | Iodine therapy for thyroidectomy patients exhibiting high thyroid-stimulating hormone values: a randomised study. | Ann R Coll Surg Engl | 1993 | https://conductscience.org/library/papers/8323210 | PubMed |
| 6263611 | Environmental factors altering thyroid function and their assessment. | Environ Health Perspect | 1981 | https://conductscience.org/library/papers/6263611 | PubMed |
| 6199072 | Are antithyroid drugs immunosuppressive? | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6199072 | PubMed |
| 4177096 | Evaluation of discordant laboratory data in patients with thyroid disorders. | J Clin Pathol | 1968 | https://conductscience.org/library/papers/4177096 | PubMed |
| 4131567 | Treatment of thyrotoxicosis. | Calif Med | 1970 | https://conductscience.org/library/papers/4131567 | PubMed |
| 761978 | Thyroid hormones in serum: effects of x-ray contrast media. | Ir J Med Sci | 1979 | https://conductscience.org/library/papers/761978 | PubMed |
| 47660 | Hyperthyroidism, results of treatment--an appraisal. | Ulster Med J | 1975 | https://conductscience.org/library/papers/47660 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4158239
GET https://conductscience.org/api/papers/v1/4158239/authors